SCHEMBL31301282

SCHEMBL31301282

Cc1ccc(-c2nccc(C(=O)N(C)c3ccc(Cl)cc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 8/20 0.51
PIK3CD O00329 1/20 0.44
PIK3CB P42338 1/20 0.44
PI4KA P42356 1/20 0.44
PIK3CG P48736 1/20 0.44
PIK3C3 Q8NEB9 1/20 0.44
MAP4K4 O95819 1/20 0.44
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CHEK2 O96017 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301327 0.95 MAP4K4 (0.48) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL31301452 0.82 GPBAR1 (0.53) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL31301274 0.82 GPBAR1 (0.53) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL31301440 0.79 GPBAR1 (0.55) GPBAR1MAPTSMN1; SMN2HSD17B1HSD17B2
SCHEMBL6643741 0.78 KMT2A (0.50) MAP4K4MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL31301429 0.78 GPBAR1 (0.51) GPBAR1MAP4K4MAPTSMN1; SMN2HSD17B1
SCHEMBL31301472 0.78 KMO (0.57) GPBAR1PIK3CGMAP4K4MAPTSMN1; SMN2
SCHEMBL31301616 0.78 KMO (0.57) GPBAR1PIK3CGMAP4K4MAPTSMN1; SMN2
SCHEMBL31301535 0.76 CNR2 (0.51) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL23367841 0.75 SMN1; SMN2 (0.60) GPBAR1MAPTSMN1; SMN2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS GPBAR1 803/4885PIK3CD 1087/4885PIK3CB 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.